Basophil Activation Tests for Allergy Diagnosis

  • Alain L. de Weck
  • Maria Luisa Sanz
Part of the Allergy Frontiers book series (ALLERGY, volume 4)

The basis and rationale for the flow cytometric basophil activation test (BAT) are reviewed. Numerous clinical applications have been found and experimented, among which allergy to inhalant allerges, to hymenoptera venoms, to latex and to food play prominent place. BAT plays a particular role in drug hypersensitivity, particularly to myorelaxants, betalactam antibiotics, pyrazolones and non steroidal anti-inflammatory drugs (NSAIDs). However, several points about the indications, the performance and the interpretation must be considered in order to obtain optimal results.


Allergy Clin Immunol Chronic Urticaria Basophil Activation Human Basophil Basophil Activation Test 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schroeder J.T., MacGlashan D.W. Jr., Lichtenstein L.M. (2001) Human basophils: mediator release and cytokine production. Adv Immunol, 77:93–122PubMedCrossRefGoogle Scholar
  2. 2.
    Benveniste J. (1981) The human basophil degranulation test as an in vitro method for diagnosis of allergies. Clin Allergy, 11:1–11PubMedCrossRefGoogle Scholar
  3. 3.
    Hamilton R.G., Adkinson N.F. (2003) Clinical laboratory assessment of IgE-dependent hyper-sensitivity. J Allergy Clin Immunol, 111 (Suppl 2):S687–701PubMedCrossRefGoogle Scholar
  4. 4.
    De Weck A.L., Sanz M.L. (2004) Cellular Allergen Stimulation Test (CAST) 2003, a review. J Investig Allergy Clin Immunol, 14:253–27Google Scholar
  5. 5.
    Sanz M.L., Maselli J.P., Gamboa P.M., Garcia-Aviles M.C., Oehling A., Diéguez I., de Weck A.L. (2002) Flow-cytometric basophil activation test. A review. J Invest Allergol Clin Immunol, 12:143–154Google Scholar
  6. 6.
    De Weck A.L., Sanz M.L. (2002) Flow cytometric Cellular Allergen Stimulation Test (FAST/ Flow CAST):technical and clinical evaluation of a new diagnostic test in allergy and pseudo-allergy. ACI Int, 14:204–215Google Scholar
  7. 7.
    Ebo D.G., Hagendorens M.M., Bridts C.H., Schuerwegh A.J., De Clerk L.D., Stevens W.J. (2004) In vitro allergy diagnosis: should we follow the flow? Clin Exp Allergy, 34:332–339PubMedCrossRefGoogle Scholar
  8. 8.
    Demoly P., Lebel B., Arnoux B. (2003) Allergen-induced mediator release tests. Allergy, 58:553–558PubMedCrossRefGoogle Scholar
  9. 9.
    Ebo D.G., Sainte-Laudy J., Bridts C.H., Mertens C.H., Hagendorens M.M., Schuerwegh A.J., De Clerck L.S, Stevens W.J. (2006) Flow-asisted allergy diagnosis: current application and future perspectives. Allergy, 61:1028–1039PubMedCrossRefGoogle Scholar
  10. 10.
    Boumiza R., Debard A.L., Monneret G. (2005) The basophil activation test by flow cytometry: recent developments in clinical studies, standardization and emerging perspectives. Clin Mol Allergy, 3:9PubMedCrossRefGoogle Scholar
  11. 11.
    Sanz M.L., Gamboa P.M., De Weck A.L. (2007) In vitro tests: Basophil activation tests. In Pichler W (ed). Drug Hypersensitivity, Karger, Basel, pp 389–400Google Scholar
  12. 12.
    MacGlashan D.W. Jr. IgE and Fcepsilon R1 regulation. NY (2005) Acad Sci, 1050:73–88CrossRefGoogle Scholar
  13. 13.
    Kleine-Tebbe J., Erdmann S., Knol E.F., MacGlashan D.W. Jr., Poulsen L.K., Gibbs B.F. (2006) Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. Int Archs Allergy Immunol, 141:79–90CrossRefGoogle Scholar
  14. 14.
    Knol E.F., Koendeman L., Mul F.P., Verhoeven A.J., Roos D. (1991) Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and independent activation pathways. Eur J Immunol, 21:881–885Google Scholar
  15. 15.
    Dahinden C.A., Kurimoto J., Baggiolini M., Dewald B., Walz A. (1989) Histamine and sulfidoleukotriene release from human basophils: Different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil-activating peptide NAF. Int Arch Allergy Appl Immunol, 90:113–118PubMedGoogle Scholar
  16. 16.
    MacGlashan D.W. Jr., Warner J. (1991) Stimulus-dependent leukotriene release from human basophils: a comparative study of C5a and Fmet-leu-phe. J Leukoc Biol, 49:20–40Google Scholar
  17. 17.
    De Weck A.L., Sanz M.L., Gamboa P.M., Aberer W., Bienvenu J., Blanca Demoly P., Ebo D.G., Mayorga L., Monneret G., Sainte-Laudy J. (2008) Diagnostic tests based on human basophils: more potentials and persepctives than pitfalls. Int Archs Allergy, 146:177–189CrossRefGoogle Scholar
  18. 18.
    Bühring H.J., The basophil-specific ectoenzyme (2004) E — NPP3 (CD 203c) as a marker for cell activation and allergy diagnosis. Int Arch Allergy Immunol, 133: 317–329PubMedCrossRefGoogle Scholar
  19. 19.
    Hennersdorf F., Florian S., Jakob A., Baumgartner K., Sonneck K., Nordheim A., Biedermann T., Valent P., Buhring H.J. (2005) Identification of CD13, CD107a, and CD 164 as novel basophil activation markers and dissection of two reaction patterns in time kinetics of IgE-dependent upregulation. Cell Res, 15:326–335CrossRefGoogle Scholar
  20. 20.
    Nakagawa T., Stadler B.M., De Weck A.L. (1981) Flow-cytometric analysis of human basophil degranulation. I. Quantification of human basophils and their degranulation by flow-cytometry. Allergy, 36:39–47Google Scholar
  21. 21.
    Gane P., Pecquet C., Crespeau H., Lambin P, Abuaf N., Leynadier F. (1993) Flowcytometric evaluation of human basophils. Cytometry, 14:344–348PubMedCrossRefGoogle Scholar
  22. 22.
    Knol E.F., Mul F.P.J., Jansen H.,Calafat J., Roos D.l. (1991) Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol, 88:328–338PubMedCrossRefGoogle Scholar
  23. 23.
    Sainte-Laudy J., Sabbah A., Vallon C., Guérin J.C. (1998) Analysis of anti-IgE and allergen induced human basophil activation by flow cytometry. Comparison with histamine release. Inflam Res, 47:401–408Google Scholar
  24. 24.
    Diamond R.A., De Maggio S. (2000) In living color: Protocols in Flow Cytometry and Cell Sorting. Springer, BerlinGoogle Scholar
  25. 25.
    Shreffler W.G. (2006) Evaluation of basophil activation in food allergy: present and future applications. Curr Opin Allergy Clin Immunol, 6:226–233PubMedCrossRefGoogle Scholar
  26. 26.
    Abuaf N., Rajoely B., Ghazouani E., Levy D.A. Pecquet C., Chabane H., Leynadier F. (1999) Validation of flow cytometry assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J. Allergy Clin Immunol, 104:411–418PubMedCrossRefGoogle Scholar
  27. 27.
    Sainte-Laudy J., Sabbah A., Drouet M., Lauret M.G., Loiry M. (2000) Diagnosis of venom allergy by flow cytometry. Correlation with cinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy, 30:1166–1171Google Scholar
  28. 28.
    Dvorak A.M. (1998) Cell biology of the basophil. Int Rev Cytol, 180:87–236PubMedCrossRefGoogle Scholar
  29. 29.
    Greiner M., Pfeiffer D., Smith R.D. (2000) Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med, 45:23–41PubMedCrossRefGoogle Scholar
  30. 30.
    Sainte_Laudy J., Valon C., Guérin J.C. (1994) Analyse de l'expression membranaire du mar-queur CD63 par activation du basophile humain. Application au diagnostic allergologique. Allergie et Immunologie, 26:211–214Google Scholar
  31. 31.
    Sanz M.L., Sanchez G., Gamboa P.M., Vila L., Uasuf C., Chazot M., Dieguez I., De Weck A.L. (2001) Allergen-induced basophil activation: CD63 cell expression detected by flow cytometry in patients allergic to Dermatophagoides pteronyssinus and Lolium perenne. Clin Exp Allergy, 31:1007–1013PubMedCrossRefGoogle Scholar
  32. 32.
    Eberlein-König B., Schmidt-Leidescher C., Rakoski J., Behrendt H., Ring J. (2006) In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy. J Investig Allergol Clin Immunol, 16:5–10PubMedGoogle Scholar
  33. 33.
    Sturm G.J., Bohm E., Trummer M., Weiglhofer I., Heinemann A., Aberer W. (2004) The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study. Allergy, 59:1110–1117PubMedCrossRefGoogle Scholar
  34. 34.
    Ebo D.G., Hagendorens M.M., Schuerwegh A,J,, Beirens L.M-N., Bridts C.H., De Clerck L.S., Stevens W.J., (2007) Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom.specific immunotherapy. Cytometry B Clin Cytom, 72: 196–203PubMedGoogle Scholar
  35. 35.
    Scherer K., Weber J.M., Jermann T..M., Krautheim A., Keefe D., de Weck A.L., Bircher A.J. (2005) The use of cellular in vitro assays in the diagnosis of hymenoptera venom allergy. J Allergy Clin Immunol, 115:S108CrossRefGoogle Scholar
  36. 36.
    Ebo D.G., Hagendorens M.M., Ridts C.H., DeClerck L.S., Stevens W.J. (2007) Hymenoptera venom allergy: Taking the sting out of difficult cases. J Investig Allergol Clin Immunol, 17:357–360PubMedGoogle Scholar
  37. 37.
    Gober L.M., Eckman J.A., Sterba P.M., Vasagar K., Schroeder J.T., Golden D.B., Saini S.S. (2007) Expression of activation markers on basophils in a controlled mode of anaphylaxis. J Allergy Clin Immunol, 119:1181–1188PubMedCrossRefGoogle Scholar
  38. 38.
    Garcia B.E., Sanz M.L., Gato J.J., Fernandez J., Oehling A. (1993) IgG4 blocking effect on the release of antigen-specific histramine. J Investig Allergol Clin Immunol, 3:26–33PubMedGoogle Scholar
  39. 39.
    Sanz M.L., Gamboa P.M., Garcia-Aviles C., Vila L., Dieguez I., Antepara I., de Weck A.L. (2003) Flow-cytomteric cellular allergen stimulation test in latex allergy. Int Arch Allergy Immunol, 130:33–39PubMedCrossRefGoogle Scholar
  40. 40.
    Ebo D.G., Lechkar B., Schuerwegh A,J,, Bridts C.H., De Clerk L.S., Stevens W.J. (2002) Validation of a two-color flow cytometric assay detecting in vitro basophil activation for the diagnosis of IgE-mediated natural rubber latex allergy. Allergy, 57:706–712PubMedCrossRefGoogle Scholar
  41. 41.
    Sanz M.L., Garcia-Aviles M.C., Tabar A.I., Anda M., Garcia B.E., Barber D., Salcedo G., Rihs H.P., Raulf-Heimsoth M. (2006) Basophil activation test and specific IgE measurements using a panel of recombinant natural rubber latex allergens to determine the latex allergen sensitization in children. Pediatric Allergy Immunol, 17:148–156CrossRefGoogle Scholar
  42. 42.
    Hemery M.L., Arnoux B., Dhivert-Donnadieu H., Rongier M., Barbotte E., Verdier R., Demoly P. (2005) Confirmation of the diagnosis of natural rubber latex allergy by tzhe Basotest method. Int Arch Allergy Clin Immunol, 136:53–57CrossRefGoogle Scholar
  43. 43.
    Boumiza R., Monneret G., Forissier M.F., Savoye J., Gutowski M.C., Powell W.S., Bienvenu J. (2003) Marked improvement of the basophil activation test by detecting CD203 c instead of CD63. Clin Exp Allergy, 33:259–265PubMedCrossRefGoogle Scholar
  44. 44.
    Mari A. (2002) IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int Arch Allergy Appl Immunol 129:286–295CrossRefGoogle Scholar
  45. 45.
    Moneret-Vautrin D., Sainte-Laudy J., Kanny G., Frémont S. (1999) Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy. Ann Allergy Asthma Immunol 82:33–40PubMedCrossRefGoogle Scholar
  46. 46.
    Diaz-Perales A., Sanz M.L., Garcia-Casado G., Sanchez-Monge R., Garcia-Selles F.J., Lomberadero M., Polo F., Gamboa P.M., Barber D., Salcedo G. (2002) Recombinant Pru p 3 and natural Pru p 3, a major peach allergen, show equivalent immunologic reactivity: a new tool for the diagnosis of fruit allergy. J Allergy Clin Immunol, 111:628–633CrossRefGoogle Scholar
  47. 47.
    Erdmann S.M., Sachs B., Schmidt A., Merk H.F., Scheiner O., Moll-Slodowy S., Sauer I., Kwiecien R., Maderegger B., Hoffmann-Sommergruber K. (2005) In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test. Int Arch Allergy Immunol, 136:230PubMedCrossRefGoogle Scholar
  48. 48.
    Ebo D.G., Hagendorens M.M., Bridts C.H., Schuerwegh A.J., DeClerck I.S., Stevens W.J. (2005) Flow cytometric analysis of in vitro activated basophils, specific IgE and skin tests in the diagnosis of pollen-associated food allergy. Cytometry B Clin Cytom, 64:28–33PubMedGoogle Scholar
  49. 49.
    Gamboa P.M., Caceres O., Antepara I., Sanchez-Monge R., Ahrazem O., Salcedo G., Berber D., Lombardero M., Sanz M.L. (2007) Two different profiles of peach allergy in the north of Spain. Allergy, 62:408–414PubMedCrossRefGoogle Scholar
  50. 50.
    Ballmer B.K., Weber J.M., Vieths S., Wühtrich B. (2008) Predictive value of the sulfidoleukotriene release assay (CAST-ELISA) in oral allergy syndrome to celery, hazelnut and carrot. J Investig Allergol Clin Immunol. 18:93–99Google Scholar
  51. 51.
    De Swerdt A., Van Den K.C., Ksran A., Cadot P., Neyens K., Coorevits L., Kochuyt A.M., Degreef H., Ceuppens J.L. (2005) Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD63. J Allergy Clin Immunol, 116:662–667PubMedCrossRefGoogle Scholar
  52. 52.
    Frezzolini A., Provini A., Teofoli P., Pomponi D., De Pita O. (2006) Serum-induced basophil CD63 expression by means of a tricolour flowvytometric method for the in vitro diagnosis of chronic urticaria. Allergy, 61:1071–1077PubMedCrossRefGoogle Scholar
  53. 53.
    Grattan C.E.H., Walpole D., Francis D.M., Niimi D.M., Dooston G., Edler S., Corbett M.F., Barr R.M. (1997) Flow cytometric analysis of nasophil numbers in chronic urticaria: basope-nia is related to serum histamine releasing activity. Clin Exp Allergy, 27:1417–1424PubMedCrossRefGoogle Scholar
  54. 54.
    Gyimesi E., Sipka S., Danko K., Kiss E., Hidvegi B., Gal M., Hunyadi J., Irinyi B., Szegedi A. (2004) Basophil CD63 expression assay on highly sensitized atopic donor leukocytes — a useful method inn chronic autoimmune urticaria. Br J Dermatol, 151:388–396PubMedCrossRefGoogle Scholar
  55. 55.
    Szegedi A., Irinyi B., Gal M., Hunyadi J., Danko K., Kiss E., Sipka S., Szegedi G., Gyomesi E. (2006) Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria. Br J Dermatol, 155:67–75PubMedCrossRefGoogle Scholar
  56. 56.
    Vasagar K., Vonakis B.M., Gober L.M., Viksman A., Gibbons S.P. Jr., Saini S.S. (2006) Evidence of in vivo basophil activation in chronic urticaria. Clin Exp Allergy, 36:770–776PubMedCrossRefGoogle Scholar
  57. 57.
    Wedi B., Novacovic V., Koerner M., Kapp A. (2000) Chronic urticaria serum induces hista-mine release, leukotriene production and basophil CD63 surface expression- inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 105:552–560PubMedCrossRefGoogle Scholar
  58. 58.
    Monneret G., Benoit Y., Debard A.L., Gutowski M.C., Topenot I., Bienvenu J. (2002) Monitoring of basophil activation using CD63 and CCR3 in allergy to muscle relaxant drugs. Clin Immunol, 102:192–199PubMedCrossRefGoogle Scholar
  59. 59.
    Sudheer P.S., Hall J.E., Read G.F., Rowbottom A.W., Williams P.E. (2005) Flowcytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c. Anaestzhesia, 60:251–256CrossRefGoogle Scholar
  60. 60.
    Kvedariene V., Kamey S., Ryckwaert Y., Rongier M., Bousquet J., Demoly P., Arnoux B. (2006) Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluor-imteric anapysis of basophils. Allergy, 61:311–315PubMedCrossRefGoogle Scholar
  61. 61.
    Ebo D.G., Bridts C.H., Hagendorens M.M., Mertens C.H., De Clerck L.S., Stevens W.J. (2006) Flow-assisted diagnostic management of anaphylaxis from rocuronium bromide. Allergy, 61:935–939PubMedCrossRefGoogle Scholar
  62. 62.
    Sanz M.L., Gamboa P.M., Uasuf C., Vila L., Garcia-Aviles C., Chazot M., De Weck A.L. (2002) Flow-cytometric basophil activation test by detection of CD63 expression in patients with immedate type reactions to betalactam antibiotics. Clin Exp Allergy, 32:277–286PubMedCrossRefGoogle Scholar
  63. 63.
    De Weck A.L., Gamboa P.M., Sanz M.L. (2002) Clinical evaluation of in vitro tests in diagnosis of immediate allergic reactions to Betalactam antibiotics. ACI Int, 14:185–192Google Scholar
  64. 64.
    Torres M.J., Padial A., Mayorga C., Fernandez T., Sanchez-Sabate E., Cornejo-Garcia A., Antunez C., Blanca M. (2004) The diagnostic interpretation of basophil activation test in immedaite allergic reactions to betalactams. Clin Exp Allergy, 34:1768–1775PubMedCrossRefGoogle Scholar
  65. 65.
    De Weck A.L., Sanz M.L., Gampoa PM, Aberer W., Bilo B., Blanca M., Torres M., Mayorga L., Campi P., Drouet M., Sainte-Laudy J., Romano A., Jermann T. Weber J.M and the ENDA group. (2006) Diagnosis of immediate-type Betalactam allergy in vitro by flow-cytometry (Flow-CAST) and sulphidoleikotriene production. A multicentric study. EAACI Vienna, p 686Google Scholar
  66. 66.
    Gamboa P.M., Garcia-Aviles M.C., Urrutia I., Antepara I., Esparza R., Sanz M.L. (2004) Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests. J Invest Allergol Clin Immunol, 14:278–283Google Scholar
  67. 67.
    Blanca M., Mayorga C., Torres M.J., Reche M., Moya M.C., Rodriguez J.L., Romano A., Juarez C. (2001) Clinical evaluation of Pharmacia CAP system RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy, 56:862–870PubMedCrossRefGoogle Scholar
  68. 68.
    Fontaine C., Mayorga C., Bousquet P.J., Arnoux B., Torres M.J., Blanca M., Demoly P. (2007) Relevance of the determination of serum specific IgE antibodies in the diagnosis of immediate Beta-lactam allergy. Allergy, 62:47–52PubMedCrossRefGoogle Scholar
  69. 69.
    Gamboa P.M., Sanz M.L., Caballero M.R., Antepara I., Urrutia I., Jauregui I., Gonzales G., Dieguez I., de Weck A.L. (2003) Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients. Allergy, 58:312–317PubMedCrossRefGoogle Scholar
  70. 70.
    Sanz M.L., Gamboa P., de Weck A.L. (2005) A new combined test with flowcytometric basophil activation anddetermination of sulfidoleukotrienes Is useful for in vitro diagnosis of hypersensitivity to aspirin and other nosteroidal anti-imnflammatory drugs. Int Arch Allergy, 36:58–72CrossRefGoogle Scholar
  71. 71.
    Gamboa P., Sanz M.L., Caballero M.R., Urrutia I., Antepara I., Esparza I., de Weck A.L. (2004) The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy, 34:1448–1457PubMedCrossRefGoogle Scholar
  72. 72.
    De Weck A.L., Sanz ML, Gamboa PM, Aberer W, Sturm G., Blanca M, Torres M, Mayorga L, Correia S, Kowalski M, Medrala W, Sczeklik A, and ENDA group. (2006) Diagnosis of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in vitro by flowvytometry (Flow-CAST) and sulfidoleukotriene assay. A multicentric study. EAACI Vienna, p 653Google Scholar
  73. 73.
    De Weck A.L., Sanz M.L., Gamboa P.M. (2007) Further considerations on the mechanism of NSAID hypersensitivity. CIA Symposium (Ring, J., Holgate, S., Kay, B. Eds) Hogrefe & Huber, Göttingen, J World Allergy Org, Suppl. 2:297–300Google Scholar
  74. 74.
    De Weck A.L., Gamboa P.M., Esparza R., Sanz M.L. (2006) Hypersensitivity to aspirin and other nonsteroidal ati-inflammarory drugs (NSAIDs) Curr Pharm Des, 2006; 12:3347–3458CrossRefGoogle Scholar
  75. 75.
    Schäfer D., Lindenthal U., Wagner M., Bölcksei P.L., Baenkler H.W. (1996) Effect of pros-taglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflammed mucosa. Thorax, 51:919–929PubMedCrossRefGoogle Scholar
  76. 76.
    Szczeklik A., Stevenson D. (2003) Aspirin-induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol, 111:913–921PubMedCrossRefGoogle Scholar
  77. 77.
    Sainte-Laudy J. (2002) Nine cases of suspected IgE-mediated anaphylaxis induced by aspirin. ACI Int, 14:220–222Google Scholar
  78. 78.
    Kosnik M., Silar M., Bajrovic N., Music E., Korosec P. (2005) High sensitivity of basophils predicts side effects in venom immunotherapy. Allergy, 60:1401–1406PubMedCrossRefGoogle Scholar
  79. 79.
    Eberlein-König B., Schmodt-Leidescher C., Begrendt H, Ring J. (2006) Predicting side-effects in venom immunotherapy by basophil activation? Allergy, 61:897PubMedCrossRefGoogle Scholar
  80. 80.
    Sainte-Laudy J., Le Provost A., André C., Vallon C. (1995) Comparison of four methods for human basophil activation measurement: alcian blue staining, histamine and LTC4 release and flow cytometry. In Proceedings of the 16th EAACI Congress (Basomba A., Hernadez M.D., De Rojas F. Eds), 257–260Google Scholar
  81. 81.
    Renz H., Becker W.M., Bufe A., Kleine-Tebbe J., Raulf-Heimsoth M., Saloga J., Werfel T., Worm M. (2002) In vitro Allergie-Diagnostik. Allergo J, 11:492–506Google Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Alain L. de Weck
    • 1
  • Maria Luisa Sanz
    • 1
  1. 1.Department of Allergology and Clinical ImmunologyClinica Universitaria, University of NavarraPamplonaSpain

Personalised recommendations